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Summary Studies were performed to determine the location, with respect to cell cycle phase, of the
radiobiologically hypoxic cells in KHT sarcomas. Cells dispersed from solid KHT tumours were separated
into subpopulations at different stages of the cell cycle by centrifugal elutriation. Flow cytometric analysis of
the DNA content of these subpopulations indicated that the degree of synchrony that could be achieved was
>95% for GI cells, 70-75% for S cells and 70-75% for G2M cells. The approach to locate and characterize
hypoxic cells was based on the premise that due to their lack of oxygen such cells would preferentially survive
radiation treatment. Consequently KHT sarcomas were irradiated in situ either in dead animals or in animals
breathing air. Following treatment, the tumours were dissociated, the cells elutriated into the various phases
of the cell cycle and clonogenic cell survival was determined. Complete dose-response curves were determined
for cells in the GI, S and G2M cell cycle phases. The various cell cycle subpopulations obtained from
tumours irradiated while mice breathed air, all demonstrated survival curves with a break and final slope
which paralleled that of the corresponding anoxic cell survival curve. From these curves the proportion of
hypoxic tumour cells in the G, phase was calculated to be 10.1+1.7%. Because the elutriated S and G2M
enriched cell fractions were to some extent contaminated by cells from other phases of the cell cycle, the
percentage of hypoxic S and G2M tumour cells was estimated to range from 0-7% and 0-5% respectively.
However, since G1 cells comprised the majority of all the neoplastic cells in these tumours, the data suggest
that hypoxic cells in KHT sarcomas are found primarily in this cell cycle stage.
There exists considerable evidence that oxygen-deficient or
hypoxic tumour cells may limit the success of radiotherapy
and certain chemotherapeutic agents (Thomlinson & Gray,
1955; Bush et al., 1978; Guichard et al., 1980; Siemann,
1984). While studies of cells made hypoxic in vitro have
yielded extensive and valuable information, it would be
desirable to be able to study directly the response of these
cells to treatment in the milieu of the tumour. This is
complicated however by the fact that factors other than
oxygenation status, such as cell cycle position, also play key
roles in determining survival following in situ treatment.
Differentiating between the relative importance of hypoxia
and cell cycle specificity in the in vivo assessment of response
to chemotherapeutic agents or radiation has been difficult,
primarily due to a lack of effective methods of isolating such
subpopulations from tumours (Meistrich et al., 1977;
Tannock, 1978; Grdina et al., 1978, 1979). However, such
evaluations may be of critical importance. For example,
evidence exists to indicate that the response of cells to
therapy can be strongly influenced by the mode of growth
(in vitro versus in vivo) at the time of treatment (Steel, 1977;
Hill et al., 1979; Sutherland et al., 1979; Martin & McNally,
1980; Siemann & Kochanski, 1981).
In a number of animal model systems we have previously
used centrifugal elutriation in conjunction with flow cyto-
metric (FCM) analysis to isolate homogeneous cell subpopu-
lations directly from solid tumours (Keng et al., 1981;
Siemann et al., 1981; Siemann & Keng, 1984, 1986). This
approach has allowed us to separate host from neoplastic
cells with a high degree of purity (Siemann et al., 1981) and
in particular, has made possible the synchronization of
neoplastic cells into the various stages of the cell cycle (Keng
et al., 1981, 1984; Siemann & Keng, 1984, 1986). The present
investigations were undertaken to determine the cell cycle
location of hypoxic cells in KHT sarcomas. Cells were
derived from tumours irradiated in situ in dead or air-
breathing mice. Homogeneous populations of cells in the
various phases of the cell cycle were obtained by centrifugal
elutriation and the fraction of hypoxic cells in each phase
then was calculated. The aim of these studies was to assess
Correspondence: D.W. Siemann.
Received 25 June 1986; and in revised form, 8 September 1986.
whether hypoxic cells were equally distributed throughout
the cell cycle phases or located predominantly in one cell
cycle stage.
Materials and methods
Animals and tumour line
The KHT sarcoma (Kallman et al., 1967), a tumour
maintained in vivo, was used in all experiments. This tumour
was passaged approximately every 2 weeks by preparing
single cell suspensions from solid tumours using a mechani-
cal dissociation procedure (Thomson & Rauth, 1974) and
injecting these cells i.m. into the hind limbs of 8-14 week old
female C3H/HeJ mice (The Jackson Laboratory, Bar
Harbor, ME). Tumours were used when they reached a size
equivalent to a weight of 0.5-0.7g.
Irradiation
The mice were irradiated whole body using a 137Cs source
operating at a dose rate of 5.5 Gy minm The animals were
not anaesthetized and were irradiated either while breathing
air or under anoxic conditions. In the latter case, the mice
were killed 10min before tumour irradiation. Immediately
following the radiation treatment, single cell suspensions
were prepared from the tumours using a combination of
mechanical and enzymatic (0.2% trypsin+ DNase) dissocia-
tion procedures (Thomson & Rauth, 1974).
Synchronization by centrifugal elutriation
Cell populations in various phases of the cell cycle were
obtained directly from solid KHT sarcomas by centrifugal
elutriation as has been described in detail elsewhere (Keng
et al., 1981; Siemann et al., 1981). Briefly, prior to use, the
elutriator system was sterilized by autoclaving and then
flushing with 70% ethanol. Approximately 1-4 x 108 cells
were suspended in 19.5 ml of alpha-minimal essential
medium plus 0.5 ml of DNase and loaded into the separation
chamber at a rotor speed of - 4000r.p.m. and a flow rate of
35 ml min- 1. During the separation procedure, the elutriator
system and the elutriation fluid (alpha-minimal essential
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medium plus 10% foetal calf serum) were held at 4°C.
The rotor speed was then decreased in increments to
-2000r.p.m. with a variable number of 40ml fractions
being collected at every interval. For each fraction collected,
the cell number and cell volume distribution were determined
using a Coulter Channelyzer system. FCM analysis was used
to determine the percentage of separated cells in the G1, S,
and G2M phases of the cell cycle as has been previously
described (Keng et al., 1981; Siemann & Keng, 1986).
Briefly, FCM measurements were made with an EPICS V
dual laser (argon and krypton) flow cytometer (Coulter
Electronics, Inc.), using a TERAK 8600 minicomputer for
data storage and analysis. Cells were fixed in 70% ethanol
and stained with mithramycin (1.Omgml-1) according to the
methods of Crissman and Tobey (1974). DNA histograms
were analyzed using the model of Fried and Mandel (1979)
implemented as the 'C CYCLE' program on the TERAK
8600 system. Data obtained previously with the KHT
sarcoma have demonstrated a close agreement between the
estimates of cells in the various phases of the cell cycle based
on FCM analysis and tritiated thymidine uptake (Keng et
al., 1981). In these experiments, the percentage of non-
neoplastic cells in each separated fraction was scored from
cytospin centrifuge prepared slides stained with Wright's and
Giemsa stains (Sieman et al., 1981).
Clonogenic cell survival assay
Following elutriation, the cells from the various fractions
collected were counted in a haemocytometer and a number
of dilutions were prepared. The cells were mixed with 104
lethally irradiated tumour cells in 0.2% agar containing
alpha-minimal essential medium supplemented with 10%
foetal calf serum and plated into 24-well multiwell plates. In
about two weeks, the surviving cells formed colonies which
were counted with the aid of a dissecting microscope.
Because unseparated cell suspensions as well as the various
elutriated cell fractions, contain different host to neoplastic
cell ratios (Siemann et al., 1981), survival values were
calculated on the basis of the number of neoplastic cells
actually plated as determined from differential counts
performed on cytospin slides (Siemann et al., 1981).
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Figure 1 Cell survival of irradiated KHT sarcoma cells in
various phases of the cell cycle. (a) Tumours irradiated in dead
mice (anoxic conditions) redrawn from Siemann and Keng
(1984). (b) Tumours irradiated in air-breathing mice. Data shown
are the mean +s.e. of 3-5 experiments.
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Results
Figure Ia shows the radiation response of anoxic KHT
sarcoma cells as a function of cell cycle stage. To induce
anoxia, tumour-bearing mice were killed 10min prior to
irradiation. The KHT sarcomas then were dissociated, the
cells elutriated and cells from each fraction were (i) prepared
for FCM and morphological analysis and (ii) plated for
clonogenic cell survival. The data, for the 3 doses evaluated
in detail, all indicated the most radiation-resistant cells to be
in the late G1 and early S phases. Early G1 cells showed
relatively greater radiation sensitivity and late S and G2M
cells were particularly sensitive. For comparison, the
tumours of air-breathing animals were irradiated with 10,
17.5 or 25 Gy and the radiation response across the cell cycle
was determined (Figure 1b). These doses were chosen to give
approximately similar levels of survival as were attained
under anoxic conditions. However, the pattern of radiation
sensitivity seen when KHT cells were irradiated in situ in air-
breathing mice was different; particularly in the G1 cell cycle
stage (Figure la vs. lb). Cells in late S and G2M were still
the most radiosensitive but now cells in the G1 phase were
most radiation resistant (Figure lb).
The fraction of hypoxic cells in the various cell cycle
phases was subsequently evaluated. Tumour cell survival
curves for KHT sarcomas irradiated with single doses of
radiation ranging from 0-35Gy under air-breathing or
anoxic conditions are illustrated in Figure 2a. The data
shown represent the response of the total cell population
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Figure 2 Cell survival following a range of radiation doses for
(a) unseparated KHT sarcoma cells or (b) cells in the G1 phase.
Tumours were irradiated under anoxic or air-breathing con-
ditions prior to cell elutriation. Data shown are the mean of 3-5
experiments +s.e. Individual points represent single experiments.
obtained from KHT tumours. Complete dose response
curves also were determined for G1, S and G2M cells
irradiated in vivo prior to cell separation. These are depicted
in Figures 2b, 3a and 3b, respectively. Under both treatment
conditions, the neoplastic cells in the elutriated cell fractions
used for cell survival evaluations had a purity, with respect
to cell cycle, of >95% for the G1 phase and 70-75% for
cells in S or G2M. The proportion of non-neoplastic host
cells in these elutriated fractions was typically < 10% for the
G1 fraction and <5% for the S and G2M fract!ons. Because
the radiation treatment was given prior to tumour dis-
sociation and cell elutriation, in all figures, each datum point
represents a separate elutriation experiment. A straight line
was fitted by linear regression to each set of data in Figures
2 and 3 for doses > 15 Gy. For every cell cycle phase
enriched fraction, analysis of covariance (Snedecor &
Cochran, 1973) found the slope of the anoxic data not to be
significantly different from the slope of the air-breathing
'.
7.0-a'--o 0
0:1
-5CHARACTERIZATION OF HYPOXIC CELLS IN KHT TUMOURS 35
a
lo1
10
i0
10-
0 10
b
- G2M anoxic
a G2 M air-
breathing
a
20 30 0 10 20 30
Dose (Gy)
Figure 3 Surviving fraction as a function of radiation dose for
KHT sarcomas irradiated under anoxic or air-breathing con-
ditions. (a) Cells in the S phase. (b) Cells in G2M. Datum points
as in Figure 2.
Table I Distribution of hypoxic tumour cells in KHT sarcomas.
Purityi aJier
Cell populaitioni elutriation1 (0%) Hpoxic ftraction (0)
Unseparated - 10.1 + 1.2b
Gl >95 10.1+1.7b
S 70_75 0-7c
G,M 70-75 0-5c
aDetermined from FCM analysis (Keng et al., 1981; Siemann &
Keng, 1986); bPercentage + SD hypoxic cells calculated from the
data shown in Figure 2 by covariance analysis (Snedecor & Cochran,
1973); cEstimated range of the percentage of hypoxic cells (see
Discussion).
data. However, when the intrinsic radiation sensitivities of
cells in the various cell fractions were compared, cells in the
G2M enriched fraction were, as has been previously reported
by us (Keng et al., 1984; Siemann & Keng, 1984), once again
the most radiosensitive.
When the tumours of air-breathing mice were irradiated,
the G1, S and G2M elutriated subpopulations all demon-
strated cell survival curves with an initial sensitive
component and resistant 'tail' at higher doses (Figures 2 and
3). This tail was parallel to the cell survival curve of the
various cell cycle subpopulations obtained when tumours
were irradiated under anoxic conditions. From these data an
estimate was made of the proportion of hypoxic cells in the
various cell cycle phases in the tumours of air-breathing mice
(Table 1). This was done by calculating cell survival ratios
under air-breathing and anoxic conditions for the same
radiation dose. The data demonstrate that KHT sarcomas
typically possess O 10% hypoxic cells, a finding in agreement
with that of others working with this tumour (Hill & Bush,
1977; Hill, 1980). These hypoxic tumour cells were not,
however, equally distributed throughout the cell cycle (Table
I). The majority were found in the G1 stage with relatively
fewer in the other phases of the cell cycle (see Discussion).
Discussion
We have previously performed experiments which determined
the survival across the cell cycle of cells grown as KHT
sarcomas (Siemann & Keng, 1984). In order to assess the
radiation response solely due to cell cycle position and to
avoid the complicating effects that variations in the cellular
oxygenation state have on cell survival, the radiation doses
were given under conditions of uniform oxygenation. These
were achieved by either irradiating the cells anoxically in
dead mice (Figure lb) or oxically in vitro after dissociation
of the tumours (Siemann & Keng, 1984). Under both
treatment conditions, cell survival increased through GI and
early S prior to decreasing continuously through mid- to late
S and into G2M (Figure Ia). In contrast, when KHT
sarcomas were irradiated under air-breathing conditions
radiation resistance remained constant through G1 to mid-S
and then decreased in late S and G2M (Figure Ib). This
latter pattern of radiation sensitivity suggested that perhaps
hypoxic conditions in the tumour were most strongly in-
fluencing the response of cells in the G1 phase of the cell
cycle.
In order to determine the cell cycle location of hypoxic
cells, complete dose response curves for each cell cycle phase
were derived from KHT tumours irradiated under anoxic or
air-breathing conditions (Figures 2 and 3). From these, the
proportion of radiobiologically hypoxic tumour cells could
be calculated (Table I). Using covariance analysis the pro-
portion of hypoxic cells in the unseparated cell suspension
and the GI fraction was found to be 10.1+1.2% and
10.1+1.7% respectively. Since the isolated G1 fraction was
.95% pure (Table I), the presence of hypoxic G1 cells in
solid KHT sarcomas seems certain. Exact computation of
the hypoxic cells in the elutriated S and G2M fractions is
however more complicated. Although the 70-75% purity
achieved in these fractions is as good as has been reported
for cells isolated directly from solid tumours, it is still
possible that the cells making up the remaining 25-30% of
the S and G2M fractions could be influencing cell survival.
For example, the S enriched fraction is contaminated by
15-20% G1 cells and the G2M enriched fraction contains
.20% S cells (Keng et al., 1981). If the contaminating cells
in these fractions, or even a portion of these cells, were
hypoxic, then the estimate of hypoxic S or G2M cells in
KHT tumours could be severely affected. For example, if all
the hypoxic cells in the S and G2M enriched fractions were
in the contaminating populations, then the actual percentage
of hypoxic S or G2M hypoxic cells could be zero. Alterna-
tively, if none of the contaminating cells in the S and G2M
enriched fractions were hypoxic, then the percentage of
hypoxic cells in these two cell cycle phases can be calculated
from Figure 3 to be 5.8+1.0% and 3.9+0.9% respectively.
The present data do not readily allow us to distinguish
between these two possibilities. Consequently, while there is
little doubt about the presence of hypoxic G1 tumour cells, it
is not possible to accurately determine the actual percentage
of hypoxic cells in the S and G2M phases. Given the
uncertainties discussed above, the percentage of hypoxic cells
in these latter two phases could range from 0-7% (S) and
0-5% (G2M).
In these investigations, cell suspensions prepared from
KHT sarcomas typically were found to contain 60-70% cells
in G1, 20-30% cells in S and 10-20% cells in G2M. Since at
least 10% of the G1 cells were hypoxic at the time of
irradiation, this suggests that the majority of all the hypoxic
cells in KHT sarcomas are in this phase of the cell cycle.
This conclusion is further supported by some of our recent
investigations of hypoxic cells in this tumour model using a
cell separation technique which depends on the diffusion
properties of the fluorochrome Hoechst 33342 (Chaplin et
al., 1985; Olive et al., 1985), and allows cells to be separated
by a cell sorter on the basis of their Hoechst 33342 staining
intensity. When applied to KHT sarcomas, 90% of the
neoplastic cells in the fraction containing the 10% most dim
cells, were in the G, phase (Siemann & Keng, in
preparation). These findings, along with the elutriation
results presented here, strongly imply that hypoxic cells in
the KHT sarcoma are located predominantly in one phase of
the cell cycle, namely G1. The results further suggest that
acute hypoxia, a consequence of intermittent opening and
closing of blood vessels (Brown, 1979; Sutherland & Franko,
1980), is not a dominant form of hypoxia in these tumours.
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Otherwise, if hypoxia in this model were primarily the result
of random intermittent changes in blood flow, then a more
uniform distribution of hypoxic cells throughout the cell
cycle would have been expected. While the results do not
rule out completely some contribution of acute hypoxia, they
are more closely aligned with chronic hypoxia being of
greater importance in KHT sarcomas.
In summary, delineation of the types of hypoxia in solid
tumours is of considerable importance. The presence of acute
and/or chronic hypoxia in tumours may have significant
impact on the choice of therapies to overcome radiation
resistance due to hypoxia. Studies of tumour cell sub-
populations may provide valuable information in this area.
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